Advertisement

Topics

Shire Sells Oncology Business to France’s Servier for $2.4 Billion

20:00 EDT 15 Apr 2018 | BioSpace

Only a couple weeks after Takeda Pharmaceuticals announced it was interested in buying Shire, Shire sells its oncology business to France’s Servier for $2.4 billion.

Original Article: Shire Sells Oncology Business to France’s Servier for $2.4 Billion

NEXT ARTICLE

More From BioPortfolio on "Shire Sells Oncology Business to France’s Servier for $2.4 Billion"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...